Oil resin resulting from CO2 supercritycal extraction of Cannabis sativa L. inflorescences.
Specification and analytical method are based on current European Pharmacopeia version
Oil resin resulting from the distillation of CBD full spectrum resin
Specification and analytical method are based on current European Pharmacopeia version
Cannabidiol obtained from Cannabis sativa L. inflorescences (CAS 13956-29-1). Content 98% to 102% (anhydrous substance).
Specification and analytical method are based on current European Pharmacopeia version and 3151 monograph.
Presentation: HDPE (High-density polyethylene) bottle 500 g Stability Studies: IVb
Oil resin resulting from CO2 supercritycal extraction of Cannabis sativa L. inflorescences.
Specification and analytical method are based on current European Pharmacopeia version.
Oil resin resulting from the distillation of THC full spectrum resin.
Specification and analytical method are based on current European Pharmacopeia version.
Dronabinol is Δ9-Tetrahydrocannabinol. It contains not less than 95% (CAS: 1972-08-3). Obtained from Cannabis sativa L. inflorescences.
Specification and analytical method are based on current European Pharmacopeia version and and USP Dronabinol monograph.
Presentation: Amber glass bottle 250 g Stability Studies: freezer condition
Flores secas, concentrados, destilados y aislados en diversas proporciones de cannabinoides para los sectores médico, farmacéutico y de bienes de consumo.